The effect of several viper venoms on prothrombin Padua
暂无分享,去创建一个
[1] E. Habermann,et al. The prothrombin-activating principle from Echis carinatus venom , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[2] E. Habermann,et al. The prothrombin-activating principle from Echis carinatus venom , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[3] A. Girolami,et al. The "echis carinatus venom" prothrombin assay in coumarin treated patients. A comparison with one-stage and immunological assays. , 1976, Folia haematologica.
[4] A. Girolami,et al. Behavior of several one-stage prothrombin time derivative tests in the abnormal factor X (factor X Friuli) coagulation disorder. , 1975, Haematologica.
[5] A. Girolami,et al. Prothrombin padua: a "new" congenital dysprothrombinemia. , 1974, The Journal of laboratory and clinical medicine.
[6] A. Govaerts,et al. Prothrombin Brussels, a new congenital defective protein. , 1974, Thrombosis research.
[7] A. Girolami. The Hereditary Transmission of Congenital ‘True’Hypoprothrombinaemia , 1971, British journal of haematology.
[8] R. Biggs,et al. The Specific Assay of Prothrombin Using the Taipan Snake Venom , 1971, British journal of haematology.
[9] J. Lavergne,et al. Congenital abnormality of the prothrombin molecule (factor II) in four siblings: prothrombin Barcelona. , 1971, Blood.
[10] A. Girolami,et al. Prothrombin Level and Activity in the Abnormal Factor X (Factor X Friuli) Hemorrhagic Disorder , 1971, Thrombosis and Haemostasis.
[11] S. Shapiro,et al. Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin. , 1969, The Journal of clinical investigation.
[12] J. Soulier,et al. Différents états moléculaires du facteur II (prothrombine). Leur étude à l’aide de la staphylocoagulase et d’anticorps anti-facteur II , 1968, Thrombosis and Haemostasis.
[13] M. Esnouf,et al. Coagulant Activity of Tiger Snake (Notechis scutatus scutatus) Venom , 1966, Nature.
[14] R. Macfarlane,et al. A Study of the Coagulant Action of Eight Snake Venoms , 1964, Thrombosis and Haemostasis.